ArticleJournal of experimental & clinical cancer research : CR2025

Targeting the HLA-E-NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG.

Yuxuan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.